EP News Bureau

Indian pharma companies have to dexterously manoeuvre contingencies by expanding their existing pipeline and secure a dominant…

The GBI Research reflects efforts by the pharma industry to remedy the unmet need in treating this disease, which is associated…

Japan will emerge as the major country in APAC region contributing 64 per cent of the revenue in 2023

42 per cent of the pipeline is in the preclinical stage, while 14 per cent is in the discovery stage and only three of drugs are…

- The lion at crossroads - Make in North East India - Make in India Achievement Report

The government is making all efforts to uphold GST and Make in India campaign as their progressive steps

Recently, a mobile app called ‘Medi-App’ was launched for chemists, which is expected to help pharma companies, distributors,…

The industry witnessed a stress in their internal sales in the month of June due to GST implementation

Experts come together to create a roadmap for the industry to transform into an entity which can effectively tackle unprecedented…